Proactive Costs of Care Study
PCOC
An Open, Single-arm, Single-site Study to Evaluate the Proactive Costs of Care (PCOC) Intervention Delivered by a Trained Lay Educator to Test Feasibility With the Goal of Improving Self-efficacy Among Patients With Gynecologic Cancer on Active Therapy and Their Caregivers
1 other identifier
interventional
36
1 country
1
Brief Summary
The Proactive Costs of Care intervention is an educational intervention designed to help patients deal with the cost of cancer care. The main goal of this trial is to evaluate whether the Proactive Costs of Care intervention can be successfully delivered to cancer patients who are starting a new treatment and their caregivers by looking at how many participants complete the intervention. The other questions the trial aims to answer are whether the intervention can:
- Improve confidence in solving problems related to costs of care
- Reduce distress related to finances Participants will complete the Proactive Costs of Care intervention, which is an approximately 30-minute one-time session with a lay educator reviewing the Proactive Costs of Care Guide and Cost Tracker. The intervention can be completed in person, by video, and by phone. Participants will also complete two surveys- one to be completed before the intervention and one to be completed 3 months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2025
CompletedFirst Posted
Study publicly available on registry
October 15, 2025
CompletedStudy Start
First participant enrolled
December 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
February 10, 2026
February 1, 2026
1.3 years
October 13, 2025
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participant Completion Rate of Educational Intervention
The number of participants who completed the intervention divided by the total number of participants who consented to the study
From enrollment to 2 months
Secondary Outcomes (2)
Change in Self-Efficacy using PROMIS Self-Efficacy
From intervention to 3 months
Change in financial distress using InCharge Financial Distress/Financial Well-Being Scale
From intervention to 3 months
Study Arms (1)
Patient and Caregiver Arm of Proactive Costs of Care Study
EXPERIMENTALNo comparator group
Interventions
Participants will receive the Proactive Costs of Care Guide that covers health insurance, employment, and finding personal and community support. They will also receive the Proactive Costs of Care Cost Tracker to help track medical costs. This one-time intervention can be completed in-person, by video, or by phone. A trained lay educator will spend approximately 30 minutes reviewing health insurance and discussing the 2-3 topics most relevant to the participant. All of the materials are available in a paper version or electronic version.
Eligibility Criteria
You may qualify if:
- Individuals 18 years old or older are included.
- Individuals diagnosed with gynecologic cancer
- On active systemic therapy within 30 days of enrollment
- Receiving treatment at Cedars-Sinai Medical Center
- Can speak, read, and understand English
- \- Caregivers to patients who satisfy the criteria above
You may not qualify if:
- Any patients whose records are flagged "break the glass" or "research opt out."
- Cannot speak, read, or understand English
- Not willing to participate in the intervention or complete surveys
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cedars-Sinai Medical Centerlead
- Merck Sharp & Dohme LLCcollaborator
- Foundation for Women's Cancerscollaborator
Study Sites (1)
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret Liang, MD, MS
Cedars-Sinai Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Staff Physician OBGYN
Study Record Dates
First Submitted
October 13, 2025
First Posted
October 15, 2025
Study Start
December 22, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share